Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 3/20 | 0.52 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.49 |
| ▸ | BCHE | P06276 | 10/20 | 0.49 |
| ▸ | ACHE | P22303 | 8/20 | 0.48 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.47 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.47 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.47 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.47 |
| ▸ | MAOA | P21397 | 1/20 | 0.46 |
| ▸ | MAOB | P27338 | 1/20 | 0.46 |
| ▸ | DPP4 | P27487 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7179229 | 0.95 | ABCG2 (0.52) | ABCG2PTPN1BCHEACHECHRNB2 | |
| SCHEMBL7186353 | 0.91 | MAOB (0.54) | ABCG2PTPN1MAOAMAOB | |
| SCHEMBL7182892 | 0.91 | MAOB (0.54) | ABCG2PTPN1MAOAMAOB | |
| SCHEMBL7184568 | 0.87 | ABCG2 (0.70) | ABCG2PTPN1MAOAMAOB | |
| SCHEMBL7184561 | 0.87 | ABCG2 (0.70) | ABCG2PTPN1MAOAMAOB | |
| SCHEMBL7183784 | 0.87 | ABCG2 (0.48) | ABCG2PTPN1BCHEACHEMAOA | |
| SCHEMBL7803247 | 0.85 | ABCG2 (0.52) | ABCG2PTPN1CHRNB2CHRNB4CHRNA3 | |
| SCHEMBL7191615 | 0.85 | ABCG2 (0.52) | ABCG2PTPN1CHRNB2CHRNB4CHRNA3 | |
| SCHEMBL7184476 | 0.84 | ABCG2 (0.64) | ABCG2PTPN1BCHEACHEMAOB | |
| SCHEMBL7184195 | 0.84 | PTPN1 (0.46) | ABCG2PTPN1BCHEACHEDPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6603046-B1 | The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. | LICA PHARMACEUTICALS A/S (DK) | 2003-08-05 | — | — | US | claimed |
| EP-0634927-B1 | TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA | LICA PHARMACEUTICALS AS (DK) | 2001-07-04 | — | — | EP | claimed |
| EP-0634927-A1 | TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA | STATENS SERUMINSTITUT (DK) | 1995-01-25 | — | — | EP | claimed |
| WO-1993017671-A1 | TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA | STATENS SERUMINSTITUT (DK) | 1993-09-16 | — | — | WO | claimed |